Clinical Trial Update: Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy [NA]

View source ↗

Summary

A terminated clinical trial compared glycemic stability between insulin aspart and insulin lispro in insulin pump therapy; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)
• insulin lispro (insulin lispro)

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Type 1 Diabetes Mellitus | NA | Status: TERMINATED | Results posted: 2017-05-30